Get the Stockscreener App
1.53
1.14%
0.00
Camp 4 Therapeutics Corp stock is traded at $1.53, with a volume of 51,933.
It is up +1.14% in the last 24 hours and down -14.51% over the past month.
Camp4 Therapeutics Corp is a clinical stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. It focuses on genetic diseases of the central nervous system and liver. The group's pipeline products are CMP-CPS-001 and CMP-SYNGAP.
See More
Previous Close:
$1.53
Open:
$1.57
24h Volume:
51,933
Relative Volume:
0.43
Market Cap:
$30.98M
Revenue:
$264.74M
Net Income/Loss:
$-49.71M
P/E Ratio:
-0.3735
EPS:
-4.0959
Net Cash Flow:
$-43.55M
1W Performance:
+0.48%
1M Performance:
-14.51%
6M Performance:
-58.74%
1Y Performance:
+286.85%
1-Day Range:
$1.475
$1.64
1-Week Range:
$1.475
$1.6999
52-Week Range:
$1.305
$12.30
Camp 4 Therapeutics Corp Stock (CAMP) Company Profile
Name
Camp 4 Therapeutics Corp
Sector
Industry
Phone
617-651-8867
Address
ONE KENDALL SQUARE, CAMBRIDGE, CA
Compare CAMP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CAMP
Camp 4 Therapeutics Corp
|
1.5367 | 31.45M | 264.74M | -49.71M | -43.55M | -4.0959 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.73 | 99.72B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
588.92 | 60.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.32 | 58.15B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
706.85 | 41.45B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
299.25 | 36.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Camp 4 Therapeutics Corp Stock (CAMP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-27-25 | Initiated | Wedbush | Outperform |
| Nov-05-24 | Initiated | JP Morgan | Overweight |
| Nov-05-24 | Initiated | Piper Sandler | Overweight |
| Nov-05-24 | Initiated | William Blair | Outperform |
| Aug-16-22 | Upgrade | Craig Hallum | Hold → Buy |
| Dec-22-21 | Downgrade | Craig Hallum | Buy → Hold |
| Sep-24-21 | Reiterated | Craig Hallum | Buy |
| Jun-25-21 | Reiterated | Craig Hallum | Buy |
| Dec-18-20 | Downgrade | JP Morgan | Neutral → Underweight |
| Apr-17-20 | Upgrade | Jefferies | Hold → Buy |
| Mar-05-20 | Reiterated | Craig Hallum | Buy |
| Dec-20-19 | Reiterated | Craig Hallum | Buy |
| Dec-20-19 | Downgrade | First Analysis Sec | Outperform → Neutral |
| Jun-28-19 | Upgrade | Northland Capital | Market Perform → Outperform |
| May-29-19 | Downgrade | Goldman | Neutral → Sell |
| May-01-19 | Reiterated | Craig Hallum | Buy |
| Mar-25-19 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-25-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-21-18 | Upgrade | Craig Hallum | Hold → Buy |
| Dec-14-18 | Reiterated | B. Riley FBR | Buy |
| Dec-11-18 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| Dec-11-18 | Downgrade | Northland Capital | Outperform → Market Perform |
| Nov-27-18 | Initiated | Goldman | Neutral |
| Oct-15-18 | Initiated | Jefferies | Hold |
| Sep-28-18 | Reiterated | Craig Hallum | Hold |
| Apr-27-18 | Reiterated | Craig Hallum | Hold |
| Mar-08-18 | Downgrade | Craig Hallum | Buy → Hold |
| Feb-16-18 | Upgrade | First Analysis Sec | Equal-Weight → Overweight |
View All
Camp 4 Therapeutics Corp Stock (CAMP) Latest News
Predicting Camp4 Therapeutics Corporation trend using moving averagesJuly 2025 Setups & Entry and Exit Point Strategies - Newser
Will breakout in Camp4 Therapeutics Corporation lead to full recoveryGold Moves & Verified Momentum Stock Alerts - Newser
Is Camp4 Therapeutics Corporation stock bottoming outJuly 2025 Catalysts & Weekly Setup with ROI Potential - Newser
What moving averages say about Camp4 Therapeutics Corporation2025 Institutional Moves & Short-Term Trading Alerts - Newser
How to read the order book for Camp4 Therapeutics CorporationGold Moves & Breakout Confirmation Trade Signals - Newser
Is this a good reentry point in Camp4 Therapeutics CorporationWeekly Profit Summary & Real-Time Buy Signal Alerts - Newser
Analysts Apply Wyckoff Model to Camp4 Therapeutics Corporation StockShare Buyback & Reliable Intraday Trade Plans - Newser
What Fibonacci levels say about Camp4 Therapeutics Corporation reboundMarket Activity Recap & Daily Volume Surge Signals - Newser
How sentiment analysis helps forecast Camp4 Therapeutics CorporationPortfolio Return Report & Fast Momentum Stock Entry Tips - Newser
Advanced analytics toolkit walkthrough for Camp4 Therapeutics Corporation2025 Key Highlights & High Conviction Investment Ideas - Newser
Can Camp4 Therapeutics Corporation weather a recessionPortfolio Risk Summary & Accurate Entry and Exit Point Alerts - theviewers.co.kr
What are Camp4 Therapeutics Corporation’s recent SEC filings showing2025 Fundamental Recap & Weekly Watchlist for Hot Stocks - theviewers.co.kr
What recovery options are there for Camp4 Therapeutics Corporation2025 Key Lessons & Daily Technical Forecast Reports - Newser
Is Camp4 Therapeutics Corporation likely to announce a buybackMarket Activity Recap & AI Based Buy/Sell Signal Reports - theviewers.co.kr
Analyzing recovery setups for Camp4 Therapeutics Corporation investors2025 Institutional Moves & Fast Exit and Entry Strategy Plans - Newser
Camp4 Therapeutics Corporation Building a Base Near Support2025 EndofYear Setup & Free Reliable Trade Execution Plans - sundaytimes.kr
Is it time to cut losses on Camp4 Therapeutics Corporation2025 Support & Resistance & Risk Managed Investment Strategies - Newser
Aug Movers: Is Camp4 Therapeutics Corporation exposed to political riskBuy Signal & Daily Stock Trend Reports - theviewers.co.kr
Momentum Indicator Shows Bearish Divergence in Camp4 Therapeutics CorporationRate Cut & Precise Trade Entry Recommendations - beatles.ru
Risk Report: Will Camp4 Therapeutics Corporation outperform tech stocksQuarterly Risk Review & Accurate Intraday Trading Signals - theviewers.co.kr
Key resistance and support levels for Camp4 Therapeutics CorporationTrade Risk Summary & Long-Term Capital Growth Ideas - Newser
Is Camp4 Therapeutics Corporation meeting your algorithmic filter criteriaWeekly Profit Summary & AI Driven Stock Price Forecasts - Newser
Applying Elliott Wave Theory to Camp4 Therapeutics CorporationM&A Rumor & Verified Swing Trading Watchlists - Newser
Published on: 2025-08-19 22:15:01 - Newser
Institutional scanner results for Camp4 Therapeutics Corporation2025 Earnings Impact & Momentum Based Trading Ideas - Newser
What moving averages say about Spero Therapeutics Inc.July 2025 Momentum & Short-Term High Return Strategies - Newser
Camp 4 Therapeutics Corp Stock (CAMP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Camp 4 Therapeutics Corp Stock (CAMP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| AH Equity Partners Bio I, L.L. | 10% Owner |
Oct 15 '24 |
Buy |
11.00 |
727,272 |
7,999,992 |
1,579,885 |
| Enavate Sciences GP, LLC | 10% Owner |
Oct 15 '24 |
Buy |
11.00 |
1,363,636 |
14,999,996 |
3,785,802 |
| Polaris Management Co. VII, L. | 10% Owner |
Oct 15 '24 |
Buy |
11.00 |
909,090 |
9,999,990 |
909,090 |
| 5AM Partners VI, LLC | 10% Owner |
Oct 15 '24 |
Buy |
11.00 |
909,090 |
9,999,990 |
2,625,145 |
| Nashat Amir | Director |
Oct 15 '24 |
Buy |
11.00 |
909,090 |
9,999,990 |
909,090 |
| Schwab Andrew J. | Director |
Oct 15 '24 |
Buy |
11.00 |
909,090 |
9,999,990 |
2,625,145 |
0.85%
8.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):